+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Radiopharmaceuticals Market by Type, Procedural Volume, Application - Global Forecast 2025-2030- Product Image
Radiopharmaceuticals Market by Type, Procedural Volume, Application - Global Forecast 2025-2030- Product Image
Sale

Radiopharmaceuticals Market by Type, Procedural Volume, Application - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 188 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 4829949
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Radiopharmaceuticals Market grew from USD 5.15 billion in 2023 to USD 5.48 billion in 2024. It is expected to continue growing at a CAGR of 6.47%, reaching USD 8.00 billion by 2030.

Radiopharmaceuticals represent a specialized niche within the pharmaceutical industry, involving radioactive compounds used primarily for diagnosis and therapy in fields such as oncology, cardiology, and neurology. The necessity of radiopharmaceuticals arises from their ability to provide unique insights into bodily functions, offering non-invasive diagnostic options and treatment pathways, particularly in cancer therapy through radioisotopes like Technetium-99m and Iodine-131. The application of radiopharmaceuticals spans medical imaging techniques such as PET and SPECT, which facilitate accurate disease diagnosis, and targeted radionuclide therapy, offering personalized medicine approaches. The market end-use spans hospitals, diagnostic centers, and academic and research institutions. Influential growth factors include an aging global population, increase in chronic diseases, technological advancements, and innovations such as theranostics that combine therapeutic and diagnostic capabilities. The latest potential opportunities include expanding markets in emerging economies, increased government funding for nuclear medicine, and innovations in hybrid imaging technologies. To leverage these opportunities, companies should enhance strategic collaborations, focus on Research and Development (R&D) to improve drug formulations, and navigate regulatory pathways efficiently. However, market growth faces challenges such as stringent regulatory requirements, high costs of development, and the short half-life of radiopharmaceuticals impacting supply chain logistics. Additionally, public perception and safety concerns regarding radiation use must be addressed. Opportunities for innovation lie in developing novel isotopes with longer half-lives, exploring AI-integrated imaging solutions that enhance diagnostic precision, and investing in automated production for cost efficiencies. The nature of the radiopharmaceutical market is highly dynamic, driven by continuous scientific discoveries and technological integration, necessitating agile strategies and a forward-looking approach in business planning to effectively capitalize on growth potentials.

Understanding Market Dynamics in the Radiopharmaceuticals Market

The Radiopharmaceuticals Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Increasing Incidence and Prevalence of Target Conditions
    • Alpha Radioimmunotherapy-Based Targeted Cancer Treatment
    • Initiatives To Reduce The Demand-Supply Gap of mo-99
  • Market Restraints
    • Shorter Life of Radiopharmaceuticals
  • Market Opportunities
    • Adoption of Radiopharmaceuticals in Neurological Applications
    • Rising Number of Diagnostic Centers Especially in Developing Countries
  • Market Challenges
    • High Equipment Prices and Limited Hospital Budget

Exploring Porter’s Five Forces for the Radiopharmaceuticals Market

Porter’s Five Forces framework further strengthens the insights of the Radiopharmaceuticals Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Radiopharmaceuticals Market

External macro-environmental factors deeply influence the performance of the Radiopharmaceuticals Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Radiopharmaceuticals Market

The Radiopharmaceuticals Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Radiopharmaceuticals Market

The Radiopharmaceuticals Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Key Company Profiles

The report delves into recent significant developments in the Radiopharmaceuticals Market, highlighting leading vendors and their innovative profiles. These include Global Medical Solutions, Siemens Healthineers AG, Fusion Pharmaceuticals Inc., Novartis AG, International Isotopes, Inc., Northstar Medical Technologies LLC, Institute of Isotopes Co. Ltd., Jubilant Pharma Holdings Inc., IsoTherapeutics Group, LLC, Eckert & Ziegler Group, Isotopia Molecular Imaging Ltd., GE HealthCare Technologies, Inc., BWX Technologies. Inc., Clarity Pharmaceuticals, Eczacibasi-Monrol Nuclear Products Co., Alliance Holdings Medical Limited, Cardinal Health, Inc., Mallinckrodt PLC, Bracco Group, NTP Radioisotopes SOC Ltd., Curium Pharma, Medi-Radiopharma, Sinotau Pharmaceutical Group, State Atomic Energy Corporation Rosatom, SHINE Medical Technologies, Lantheus Medical Imaging, Inc., Bayer AG, and BWXT Medical Ltd..

Market Segmentation & Coverage

This research report categorizes the Radiopharmaceuticals Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Type
    • Diagnostic Nuclear Medicine
      • Pet Radiopharmaceuticals
        • F-18
        • Ru-82
      • Spect Radiopharmaceuticals
        • Ga-67
        • I-123
        • Tc-99m
        • Tl-201
    • Therapeutic Nuclear Medicine
      • Alpha Emitters
      • Beta Emitters
        • I-131
        • Lu-177
        • Re-186
        • Sm-153
        • Y-90
      • Brachytherapy Isotopes
        • Cs-131
        • I-125
        • Ir-192
        • Pd-103
  • Procedural Volume
    • Diagnostic Procedures
      • Pet Radiopharmaceutical Procedure
      • Spect Radiopharmaceuticals Procedure
    • Therapeutic Procedures
      • Alpha Emitter Procedure
      • Beta Emitters Procedure
      • Brachytherapy Isotopes Procedure
  • Application
    • Diagnostic Applications
      • Pet Applications
        • Cardiology Indication
        • Neurology Indication
        • Oncology Indication
      • Spect Applications
        • Cardiology
        • Lymphoma
        • Neurology
        • Thyroid
    • Therapeutic Applications
      • Bone Metastasis
      • Endocrine Tumors
      • Lymphoma Therapeutic
      • Thyroid Therapeutic
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing Incidence and Prevalence of Target Conditions
5.1.1.2. Alpha Radioimmunotherapy-Based Targeted Cancer Treatment
5.1.1.3. Initiatives To Reduce The Demand-Supply Gap of mo-99
5.1.2. Restraints
5.1.2.1. Shorter Life of Radiopharmaceuticals
5.1.3. Opportunities
5.1.3.1. Adoption of Radiopharmaceuticals in Neurological Applications
5.1.3.2. Rising Number of Diagnostic Centers Especially in Developing Countries
5.1.4. Challenges
5.1.4.1. High Equipment Prices and Limited Hospital Budget
5.2. Market Segmentation Analysis
5.2.1. Procedural Volume: Ongoing advancements in brachytherapy isotopes procedure
5.2.2. Application: Increasing utilization of radiopharmaceuticals in therapeutic procedures
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
5.5. Client Customization
6. Radiopharmaceuticals Market, by Type
6.1. Introduction
6.2. Diagnostic Nuclear Medicine
6.2.1. Pet Radiopharmaceuticals
6.2.1.1. F-18
6.2.1.2. Ru-82
6.2.2. Spect Radiopharmaceuticals
6.2.2.1. Ga-67
6.2.2.2. I-123
6.2.2.3. Tc-99m
6.2.2.4. Tl-201
6.3. Therapeutic Nuclear Medicine
6.3.1. Alpha Emitters
6.3.2. Beta Emitters
6.3.2.1. I-131
6.3.2.2. Lu-177
6.3.2.3. Re-186
6.3.2.4. Sm-153
6.3.2.5. Y-90
6.3.3. Brachytherapy Isotopes
6.3.3.1. Cs-131
6.3.3.2. I-125
6.3.3.3. Ir-192
6.3.3.4. Pd-103
7. Radiopharmaceuticals Market, by Procedural Volume
7.1. Introduction
7.2. Diagnostic Procedures
7.2.1. Pet Radiopharmaceutical Procedure
7.2.2. Spect Radiopharmaceuticals Procedure
7.3. Therapeutic Procedures
7.3.1. Alpha Emitter Procedure
7.3.2. Beta Emitters Procedure
7.3.3. Brachytherapy Isotopes Procedure
8. Radiopharmaceuticals Market, by Application
8.1. Introduction
8.2. Diagnostic Applications
8.2.1. Pet Applications
8.2.1.1. Cardiology Indication
8.2.1.2. Neurology Indication
8.2.1.3. Oncology Indication
8.2.2. Spect Applications
8.2.2.1. Cardiology
8.2.2.2. Lymphoma
8.2.2.3. Neurology
8.2.2.4. Thyroid
8.3. Therapeutic Applications
8.3.1. Bone Metastasis
8.3.2. Endocrine Tumors
8.3.3. Lymphoma Therapeutic
8.3.4. Thyroid Therapeutic
9. Americas Radiopharmaceuticals Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Radiopharmaceuticals Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Radiopharmaceuticals Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. Bristol Myers Squibb Adds Premier Radiopharmaceutical Platform with Acquisition of RayzeBio
12.3.2. New CRP to Develop new Technetium-99m Radiopharmaceuticals for Disease Diagnosis
12.3.3. With USD 56 Million, a Mayo Clinic-backed Startup takes aim at Radiopharmaceutical Roadblocks
List of Figures
FIGURE 1. RADIOPHARMACEUTICALS MARKET RESEARCH PROCESS
FIGURE 2. RADIOPHARMACEUTICALS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2023 VS 2030 (%)
FIGURE 9. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 11. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. RADIOPHARMACEUTICALS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. RADIOPHARMACEUTICALS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. RADIOPHARMACEUTICALS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. RADIOPHARMACEUTICALS MARKET DYNAMICS
TABLE 7. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY F-18, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY RU-82, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY GA-67, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY I-123, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY TC-99M, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY TL-201, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY ALPHA EMITTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY I-131, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY LU-177, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY RE-186, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY SM-153, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY Y-90, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY CS-131, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY I-125, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY IR-192, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PD-103, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICAL PROCEDURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS PROCEDURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY ALPHA EMITTER PROCEDURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS PROCEDURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES PROCEDURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY INDICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY INDICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY INDICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY LYMPHOMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THYROID, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BONE METASTASIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY ENDOCRINE TUMORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY LYMPHOMA THERAPEUTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THYROID THERAPEUTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
TABLE 84. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 85. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 86. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
TABLE 87. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 88. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 97. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 98. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
TABLE 99. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 100. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 101. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
TABLE 102. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 103. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 112. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 113. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
TABLE 114. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 115. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 116. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
TABLE 117. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 118. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2030 (USD MILLION)
TABLE 119. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2030 (USD MILLION)
TABLE 120. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 121. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 122. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 124. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 125. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 126. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 127. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 128. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
TABLE 129. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 130. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 131. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
TABLE 132. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 133. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2030 (USD MILLION)
TABLE 134. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2030 (USD MILLION)
TABLE 135. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 136. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 137. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 138. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 139. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 140. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 141. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 142. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 143. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
TABLE 144. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 145. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 146. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
TABLE 147. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 148. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2030 (USD MILLION)
TABLE 149. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2030 (USD MILLION)
TABLE 150. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 151. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 152. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 153. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 154. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 155. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 156. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 157. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 158. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 159. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
TABLE 160. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 161. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 162. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
TABLE 163. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 164. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2030 (USD MILLION)
TABLE 165. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2030 (USD MILLION)
TABLE 166. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 167. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 168. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 169. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 170. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 171. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 172. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 173. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 174. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 175. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
TABLE 176. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 177. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 178. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
TABLE 179. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 180. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2030 (USD MILLION)
TABLE 181. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2030 (USD MILLION)
TABLE 182. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 183. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 184. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 186. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 187. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 188. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 189. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 190. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
TABLE 191. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 192. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 193. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
TABLE 194. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 195. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2030 (USD MILLION)
TABLE 196. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2030 (USD MILLION)
TABLE 197. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 198. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 199. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 200. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 201. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 202. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 203. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 204. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 205. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
TABLE 206. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 207. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 208. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
TABLE 209. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 210. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2030 (USD MILLION)
TABLE 211. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2030 (USD MILLION)
TABLE 212. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 213. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 214. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 215. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 216. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 217. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 218. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 219. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 220. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
TABLE 221. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 222. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 223. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
TABLE 224. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 225. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2030 (USD MILLION)
TABLE 226. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2030 (USD MILLION)
TABLE 227. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 228. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 229. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 230. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 231. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 232. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 233. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 234. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 235. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
TABLE 236. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 237. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 238. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
TABLE 239. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 240. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2030 (USD MILLION)
TABLE 241. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2030 (USD MILLION)
TABLE 242. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 243. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 244. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 245. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 246. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 247. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 248. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 249. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 250. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
TABLE 251. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 252. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 253. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
TABLE 254. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 255. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2030 (USD MILLION)
TABLE 256. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2030 (USD MILLION)
TABLE 257. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 258. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 259. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 260. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 261. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 262. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 263. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 264. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 265. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
TABLE 266. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 267. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 268. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
TABLE 269. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 270. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2030 (USD MILLION)
TABLE 271. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2030 (USD MILLION)
TABLE 272. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 273. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 274. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 275. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 276. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 277. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 278. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 279. SINGAPORE RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 280. SINGAPORE RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
TABLE 281. SINGAPORE RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 282. SINGAPORE RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 283. SINGAPORE RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
TABLE 284. SINGAPORE RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 285. SINGAPORE RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2030 (USD MILLION)
TABLE 286. SINGAPORE RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2030 (USD MILLION)
TABLE 287. SINGAPORE RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 288. SINGAPORE RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 289. SINGAPORE RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 290. SINGAPORE RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 291. SINGAPORE RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 292. SINGAPORE RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 293. SINGAPORE RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 294. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 295. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
TABLE 296. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 297. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 298. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
TABLE 299. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 300. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2030 (USD MILLION)
TABLE 301. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2030 (USD MILLION)
TABLE 302. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 303. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 304. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 305. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 306. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 307. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 308. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 309. TAIWAN RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 310. TAIWAN RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
TABLE 311. TAIWAN RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 312. TAIWAN RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 313. TAIWAN RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2030 (USD MILLION)
TABLE 314. TAIWAN RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 315. TAIWAN RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2030 (USD MILLION)
TABLE 316. TAIWAN RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2030 (USD MILLION)
TABLE 317. TAIWAN RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 318. TAIWAN RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 319. TAIWAN RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 320. TAIWAN RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 321. TAIWAN RADI

Companies Mentioned

The leading players in the Radiopharmaceuticals market, which are profiled in this report, include:
  • Global Medical Solutions
  • Siemens Healthineers AG
  • Fusion Pharmaceuticals Inc.
  • Novartis AG
  • International Isotopes, Inc.
  • Northstar Medical Technologies LLC
  • Institute of Isotopes Co. Ltd.
  • Jubilant Pharma Holdings Inc.
  • IsoTherapeutics Group, LLC
  • Eckert & Ziegler Group
  • Isotopia Molecular Imaging Ltd.
  • GE HealthCare Technologies, Inc.
  • BWX Technologies. Inc.
  • Clarity Pharmaceuticals
  • Eczacibasi-Monrol Nuclear Products Co.
  • Alliance Holdings Medical Limited
  • Cardinal Health, Inc.
  • Mallinckrodt PLC
  • Bracco Group
  • NTP Radioisotopes SOC Ltd.
  • Curium Pharma
  • Medi-Radiopharma
  • Sinotau Pharmaceutical Group
  • State Atomic Energy Corporation Rosatom
  • SHINE Medical Technologies
  • Lantheus Medical Imaging, Inc.
  • Bayer AG
  • BWXT Medical Ltd.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages188
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 5.48 Billion
Forecasted Market Value ( USD ) by 2030 $ 8 Billion
Compound Annual Growth Rate6.4%
Regions CoveredGlobal
No. of Companies Mentioned29

Related Topics

Related Reports

Nuclear Medicine/Radiopharmaceuticals - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Nuclear Medicine/Radiopharmaceuticals - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 100 Pages
  • Global
From
Radiopharmaceuticals - Global Strategic Business Report - Product Image

Radiopharmaceuticals - Global Strategic Business Report

  • Report
  • 739 Pages
  • Global
From
Diagnostic Radiopharmaceuticals and Contrast Media - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Diagnostic Radiopharmaceuticals and Contrast Media - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 118 Pages
  • Global
From
Radiopharmaceuticals Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2019-2029F - Product Image

Radiopharmaceuticals Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2019-2029F

  • Report
  • 180 Pages
  • Global
From
Radiopharmaceuticals Market Report by Product Type, Application, End Use, and Region 2024-2032 - Product Image

Radiopharmaceuticals Market Report by Product Type, Application, End Use, and Region 2024-2032

  • Report
  • 138 Pages
  • Global
From

About the Radiopharmaceutical Market

Radiopharmaceuticals are a type of biopharmaceutical used in medical imaging and therapy. They are typically composed of a radioactive isotope, such as technetium-99m, bound to a biologically active molecule, such as a peptide or antibody. Radiopharmaceuticals are used to diagnose and treat a variety of diseases, including cancer, cardiovascular disease, and neurological disorders. They are administered intravenously, orally, or by inhalation, depending on the type of radiopharmaceutical and the desired therapeutic effect. The radiopharmaceutical market is a rapidly growing segment of the biopharmaceutical industry. It is driven by advances in medical imaging technology, the development of new radiopharmaceuticals, and the increasing prevalence of diseases that can be treated with radiopharmaceuticals. Some of the major companies in the radiopharmaceutical market include GE Healthcare, Mallinckrodt Pharmaceuticals, Bracco Imaging, and Lantheus Medical Imaging. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.